Skip to main content
Select Search Option
Menu
Weill Cornell Medicine
  • Weill Cornell Medicine
  • Care
  • Discover
  • Teach
Richard T. Silver MD Myeloproliferative Neoplasms Center
Richard T. Silver MD Myeloproliferative Neoplasms Center
Explore this Website
  • Home
  • For Patients
    • Conditions
      • Chronic Myeloid Leukemia
      • Essential Thrombocythemia
      • Myelofibrosis
      • Polycythemia Vera
      • Chronic Eosinophilic Leukemias
      • MDS/MPN
      • MPN-Unclassifiable
      • Mastocytosis
    • Complications
      • Bleeding
      • Cardiovascular Disease (heart failure, pulmonary artery hypertension)
      • Depression and other mood disorders
      • Diarrhea and other gastrointestinal complications
      • Pregnancy and MPNs
      • Pruritus (Itching)
      • Thrombosis/Blood Clots
      • Sexual Dysfunction
    • Treatments
      • Anagrelide (Agrylin®)
      • Anti-Coagulants
      • Aspirin
      • Bone Marrow Transplant
      • Bosutinib (Bosulif®)
      • Clopidogrel (Plavix®)
      • DNA Hypomethylating Agents (DHAs)
      • Dasatinib (Sprycel®)
      • Erythropoiesis-Stimulating Agents (ESAs)
      • Hydroxyurea
      • Imatinib (Gleevec®)
      • Interferons
      • Lenalidomide (Revlimid®)
      • Nilotinib (Tasigna®)
      • Phosphorous-32
      • Ponatinib (Iclusig®)
      • Prednisone
      • Ruxolitnib
      • Tyrosine Kinase Inhibitors (TKIs)
    • Frequently Asked Questions
    • Resources
    • Your First Visit
    • Request an Appointment
  • For Professionals
    • Refer a Patient
    • Featured Publications
    • Treatment Guidelines and Recommendations
      • Essential Thrombocythemia (ET)
  • News and Updates
    • Events
  • Research and Clinical Trials
    • Open MPN Clinical Trials
    • Our Research
  • About Us
    • Our Approach
    • Our Team
    • Leadership
    • Make a Difference
    • Directions
  • Weill Cornell Medicine
  • Care
  • Discover
  • Teach
  • Home
  • For Patients
  • For Professionals
  • News and Updates
  • Research and Clinical Trials
  • About Us
  • Home
  • For Professionals
    • Refer a Patient
    • Featured Publications
    • Treatment Guidelines and Recommendations

For Professionals

Learn about our myeloproliferative neoplasm research and approach to patient care, refer a patient or contact our physician-scientists.

Clinical Trials

If you would like to learn more about our MPN research or refer a patient to enroll on one of our clinical trials, please search our MPN clinical trial database.

Patient Referrals

Complete this form to refer a patient to a physician at the Silver MPN Center. We partner with physicians around the country to offer second opinions, as well as specialize in the co-management of patients with MPNs.

Featured Publications

View our latest research publications.

Treatment Guidelines & Recommendations

The latest guidelines and recommendations in the clinical management of myeloproliferative neoplasms.

2025 MPN Congress
2025 International Congress on Myeloproliferative Neoplasms
Dr. Richard T. Silver is chairing the upcoming 2025 MPN Congress taking place November 6-7 at the New York Marriott Brooklyn Bridge. The two-day event features presentations from world-renowned experts in the field covering the latest scientific, clinical, and therapeutic developments. Learn more and register.
(646) 962-2727
Request an Appointment Medical Records Make a Difference Email List

Richard T. Silver MD Myeloproliferative Neoplasms Center 520 E 70th Street Starr Pavillion, 341 New York, NY 10021 SilverMPNCenter@med.cornell.edu

Jump To Top
Our Location
Richard T. Silver MD Myeloproliferative Neoplasms Center
Contact Us
  • Twitter
  • Facebook
  • YouTube
520 E 70th Street Starr Pavillion, 341
New York, NY 10021
Phone: (646) 962-2727
Fax: (646) 962-0115
  • For Patients
    • Conditions
      • Chronic Myeloid Leukemia
      • Essential Thrombocythemia
      • Myelofibrosis
      • Polycythemia Vera
      • Chronic Eosinophilic Leukemias
      • MDS/MPN
      • MPN-Unclassifiable
      • Mastocytosis
    • Complications
      • Bleeding
      • Cardiovascular Disease (heart failure, pulmonary artery hypertension)
      • Depression and other mood disorders
      • Diarrhea and other gastrointestinal complications
      • Pregnancy and MPNs
      • Pruritus (Itching)
      • Thrombosis/Blood Clots
      • Sexual Dysfunction
    • Treatments
      • Anagrelide (Agrylin®)
      • Anti-Coagulants
      • Aspirin
      • Bone Marrow Transplant
      • Bosutinib (Bosulif®)
      • Clopidogrel (Plavix®)
      • DNA Hypomethylating Agents (DHAs)
      • Dasatinib (Sprycel®)
      • Erythropoiesis-Stimulating Agents (ESAs)
      • Hydroxyurea
      • Imatinib (Gleevec®)
      • Interferons
      • Lenalidomide (Revlimid®)
      • Nilotinib (Tasigna®)
      • Phosphorous-32
      • Ponatinib (Iclusig®)
      • Prednisone
      • Ruxolitnib
      • Tyrosine Kinase Inhibitors (TKIs)
    • Frequently Asked Questions
    • Resources
    • Your First Visit
    • Request an Appointment
  • For Professionals
    • Refer a Patient
    • Featured Publications
    • Treatment Guidelines and Recommendations
      • Essential Thrombocythemia (ET)
  • News and Updates
    • Events
  • Research and Clinical Trials
    • Open MPN Clinical Trials
    • Our Research
  • About Us
    • Our Approach
    • Our Team
    • Leadership
    • Make a Difference
    • Directions
Care. Discover. Teach. With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and individualized clinical care, making groundbreaking biomedical discoveries, and educating generations of exceptional doctors and scientists.
Weill Cornell Medicine NewYork - Presbyterian
© Weill Cornell Medicine.
  • Privacy & Legal
  • Careers
  • Giving
  • Directory
  • Web Accessibility Assistance